Outpatient Surgery Access Act of 2026
Summary
HR8091 is an early-stage bill with no market impact yet. It would improve Medicare ASC payment rates starting in 2027 by removing budget neutrality caps and tying updates to hospital outpatient rates. Pure-play ASC operators SGRY and SEM are the direct beneficiaries if the bill advances, but it remains in committee with a single sponsor and no appropriation mechanism.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR8091 is a procedural Medicare payment modernization bill with no appropriated funds and no near-term market impact
- 2.Bill is stalled at committee referral — one sponsor, one cosponsor, no hearings, no Senate companion
- 3.If passed, pure-play ASC operators ($SGRY, $SEM) see the clearest revenue benefit from higher and uncapped Medicare rates starting 2027
- 4.No real price movement attributable to this bill — recent SGRY 30-day +17% and SEM +1.1% moves are sector/earnings driven
- 5.Enactment probability is low before 2027 given the election-year calendar and committee bandwidth
Market Implications
No measurable market implication from this bill at this time. $SGRY and current prices reflect company fundamentals and broader healthcare sector trends, not the probability of ASC payment reform. Should the bill receive a committee hearing or gain significant cosponsor momentum, the catalyst would be positive for ASC pure-plays. For now, this is a monitoring item only — no position changes warranted based on this legislation alone.
Full Analysis
-
What happened and its current status: Rep. Van Duyne (R-TX) introduced HR8091, the Outpatient Surgery Access Act of 2026, on March 25, 2026. It was referred to both the Energy and Commerce and Ways and Means Committees. The bill is in early committee-stage with no floor votes, hearings, or markups. Only one cosponsor (Rep. Larson, D-CT) has joined. There is no companion bill in the Senate. Legislative velocity is low — four actions all on the introduction date.
-
The money trail: This bill authorizes a change to Medicare payment methodology — it does NOT appropriate any funds. Starting in 2027, CMS would be required to update ASC payment rates using the same inflation factor applied to hospital outpatient departments (OPD fee schedule increase factor). The bill also prohibits CMS from applying budget neutrality adjustments exclusively to ASC services (which previously functioned as a hidden cap on ASC spending growth). Actual dollar impact depends on future OPD update factors; there is no fixed dollar amount in the legislation.
-
Structural winners and losers: Pure-play ASC operators Surgery Partners ($SGRY, ~100% ASC revenue) and Select Medical (, ~20-25% from ASCs) are the most directly positioned to benefit because Medicare ASC payments constitute a significant portion of their surgical volume revenue. Hospital-centric operators like Tenet ($THC, through USPI JV) see a net positive but diluted exposure. HCA ($HCA, heavy hospital outpatient footprint) could face modest competitive pressure if ASCs become more financially attractive for procedures that can shift sites of care.
-
Market data and price trends: As of April 30, 2026, $SGRY trades at $13.95, up 17.03% over 30 days but down 2.72% in the last 7 days. trades at $16.47, up 1.1% over 30 days. These moves are more likely driven by earnings expectations and broader sector trends rather than this early-stage bill, which has no discernible price catalyst yet. Both stocks remain well within their 52-week ranges.
-
Timeline: The bill must pass both committees (Energy & Commerce and Ways & Means), clear the House floor, pass the Senate, and be signed into law. With a single Republican sponsor and one Democratic cosponsor, bipartisan interest exists but legislative bandwidth for procedural Medicare payment changes in an election year is limited. Earliest possible effective date is January 2027 per the bill text. Near-term probability of enactment is low.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
No confirming evidence found yet from contracts, insider trades, or congressional activity
What the bill does
removal of ASC-specific budget neutrality caps and alignment of Medicare annual payment updates for ambulatory surgical centers with hospital outpatient department (OPD) fee schedule increases
Who must act
Centers for Medicare & Medicaid Services (CMS)
What happens
CMS must calculate ASC payment updates using the OPD fee schedule increase factor starting in 2027 and cannot apply a budget neutrality adjustment solely to ASC services; this is expected to produce higher annual payment rate increases for ASCs compared to current law, and eliminate a regulatory mechanism that previously capped aggregate ASC expenditure growth relative to a baseline
Stock impact
Surgery Partners derives nearly all revenue from ASC operations; higher Medicare payment rates directly improve per-case reimbursement margins across its owned and managed centers, with no offsetting hospital revenue exposure
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
MURNANE BUILDING CONTRACTORS, INC.: $32.9M General Services Administration Contract
THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA (THE GLOBAL FUND): $1.8B Department of State Federal Award
DEPARTMENT OF HUMAN SERVICES HAWAII: $2.2B Department of Health and Human Services Grant
KANSAS DEPARTMENT OF HEALTH & ENVIRONMENT: $4.6B Department of Health and Human Services Grant
NEW MEXICO HEALTH CARE AUTHORITY: $9.4B Department of Health and Human Services Grant
HEALTH SERVICES KENTUCKY CABINET FOR: $18.2B Department of Health and Human Services Grant
MULTIPLE RECIPIENTS: $4.1B Department of Health and Human Services Federal Award
ARIZONA HEALTH CARE COST CONTAINMENT SYSTEM: $19.6B Department of Health and Human Services Grant
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →